Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-24-040544)

Filing Details

Accession Number:: 0001493152-24-040544
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2024-10-09 09:58:52
Reporting Period:: 2024-10-08

Accepted Time:: 2024-10-09 09:58:52
Original Submission Date:: 2024-10-08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1861657	Tharimmune Inc.	THAR	Pharmaceutical Preparations (2834)	842642541

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1901565	Sireesh Appajosyula	C/O Tharimmune, Inc. 1200 Route 22 East, Suite 2000 Bridgewater NJ 08807	Chief Operating Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-10-08	5,000	$1.93	5,758	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,593	Indirect	See footnote
Common Stock	21	Indirect	See footnote

Footnotes

2,593 shares of common stock are held indirectly by Highpoint Pharmaceuticals, LLC and 21 shares of common stock are held by Channel BioConsulting LLC. The Reporting Person is the managing member of each of Highpoint Pharmaceuticals, LLC and Channel BioConsulting LLC and in such capacity has the right to vote and dispose of the securities held by such entities.